HYAL2 and glioma: In the TCGA and CGGA databases (mRNA-array_301, mRNAseq_325 and mRNAseq_693), the GSEA results showed that high HYAL2 expression resulted in significant enrichment of the cell cycle and apoptosis pathways in glioma (Fig. 6A, D).